Sequence information
Variant position: 104 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 142 The length of the canonical sequence.
Location on the sequence:
LSDLHAHKLRVDPVNFKLLS
H CLLVTLAAHLPAEFTPAVHA
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LSDLHAHKLRVDPVNFKLLSH CLLVTLAAHLPAEFTPAVHA
Gorilla LSDLHAHKLRVDPVNFKLLSH CLLVTLAAHLPAEFTPAVHA
LSDLHAYKLRVDPVNFKLLSH CLLVTLACHHPTEFTPAVHA
Rhesus macaque LSDLHAHKLRVDPVNFKLLSH CLLVTLAAHLPAEFTPAVHA
Chimpanzee LSDLHAHKLRVDPVNFKLLSH CLLVTLAAHLPAEFTPAVHA
Mouse LSDLHAHKLRVDPVNFKLLSH CLLVTLASHHPADFTPAVHA
Rat LSDLHAHKLRVDPVNFKFLSH CLLVTLACHHPGDFTPAMHA
Pig LSDLHAHKLRVDPVNFKLLSH CLLVTLAAHHPDDFNPSVHA
Bovine LSDLHAHKLRVDPVNFKLLSH SLLVTLASHLPSDFTPAVHA
Rabbit LSDLHAHKLRVDPVNFKLLSH CLLVTLANHHPSEFTPAVHA
Sheep LSDLHAHKLRVDPVNFKLLSH SLLVTLACHLPNDFTPAVHA
Cat LSDLHAYKLRVDPVNFKFLSH CLLVTLACHHPAEFTPAVHA
Horse LSDLHAHKLRVDPVNFKLLSH CLLSTLAVHLPNDFTPAVHA
Chicken LSDLHAHKLRVDPVNFKLLGQ CFLVVVAIHHPAALTPEVHA
Xenopus tropicalis LSDLHAYDLRVDPGNFPLLAH QILVVVAIHFPKQFDPATHK
Zebrafish LSELHAFKLRVDPANFKILSH NVIVVIAMLFPADFTPEVHV
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Literature citations
The characterization of hemoglobin Manitoba or alpha (2)102(G9)Ser----Arg beta 2 and hemoglobin Contaldo or alpha (2)103(G10)His----Arg beta 2 by high performance liquid chromatography.
Sciarratta G.V.; Ivaldi G.; Molaro G.L.; Sansone G.; Salkie M.L.; Wilson J.B.; Reese A.L.; Huisman T.H.;
Hemoglobin 8:169-181(1984)
Cited for: VARIANT MANITOBA ARG-103; VARIANT CONTALDO ARG-104;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.